tert-Butyl (1,2,3,4-tetrahydroisoquinolin-5-yl)carbamate

Catalog No.: 
ACWOXE784
CAS No.: 
887591-04-0
Molecular Formula: 
C14H20N2O2
Molecular Weight: 
248.33
tert-Butyl (1,2,3,4-tetrahydroisoquinolin-5-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$252.00InquiryInquiry
100mg95%$368.00In stockInquiry
250mg95%$518.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (1,2,3,4-tetrahydroisoquinolin-5-yl)carbamate
IUPAC Nametert-butyl (1,2,3,4-tetrahydroisoquinolin-5-yl)carbamate
Molecular FormulaC14H20N2O2
Molecular Weight248.33
SMILESO=C(OC(C)(C)C)NC1=CC=CC2=C1CCNC2
InChI KeyJXHAKLFEWQOFND-UHFFFAOYSA-N
Synonymtert-Butyl (1,2,3,4-tetrahydroisoquinolin-5-yl)carbaMate;(1,2,3,4-TETRAHYDRO-ISOQUINOLIN-5-YL)-CARBAMIC ACID TERT-BUTYL ESTER;tert-butyl N-(1,2,3,4-tetrahydroisoquinolin-5-yl)carbamate;Carbamic acid, (1,2,3,4-tetrahydro-5-isoquinolinyl)-, 1,1-dimethylethyl ester (9CI)
CAS No.887591-04-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACWOXE784 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWOXE784 route product structure diagram
    ACWOXE784887591-04-0In Stock
Inquiry

2. ACWOXE784 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWOXE784 route product structure diagram
    ACWOXE784887591-04-0In Stock
Inquiry

3. ACWOXE784 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWOXE784 route product structure diagram
    ACWOXE784887591-04-0In Stock
Inquiry

Comments (0)